Drug interactions for the following drug(s)
Applies to: prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule <> prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule
Prazosin may increase the hypotensive activities of Polythiazide.
Applies to: prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule <> Verapamil hydrochloride 180 MG Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Prazosin is combined with Verapamil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule <> prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule
Drug1 (rxcui = 312481, name = Polythiazide 0.5 MG / Prazosin 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 312481, name = Polythiazide 0.5 MG / Prazosin 1 MG Oral Capsule, tty = SCD). Drug1 is resolved to Polythiazide, Drug2 is resolved to Prazosin and interaction asserted in DrugBank between Polythiazide and Prazosin. Drug1 is resolved to Prazosin, Drug2 is resolved to Polythiazide and interaction asserted in DrugBank between Prazosin and Polythiazide.
Applies to: prazosin HCl 1 MG / polythiazide 0.5 MG Oral Capsule <> Verapamil hydrochloride 180 MG Extended Release Oral Tablet
Drug1 (rxcui = 312481, name = Polythiazide 0.5 MG / Prazosin 1 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 897640, name = Verapamil hydrochloride 180 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to Prazosin, Drug2 is resolved to Verapamil and interaction asserted in DrugBank between Prazosin and Verapamil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.